Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials

International Journal of Radiation Oncology, Biology, Physics

Volumn 27, Issue 2, 1993, Pages 241-250

  Haffty, Bruce G ^a   Son, Yung H ^a   Sasaki, Clarence T ^a   Papac, Rose ^a   Fischer, Diana ^a   Rockwell, Sara ^a   Sartorelli, Alan ^a   Fischer, James J ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

Head and neck cancer; Mitomycin C; Radiation therany

Indexed keywords

BLEOMYCIN; CISPLATIN; DICOUMAROL; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; SKIN INFLAMMATION; SKIN ULCER; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DICUMAROL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMAN; MALE; MIDDLE AGE; MITOMYCIN; POSTOPERATIVE PERIOD; SUPPORT, NON-U.S. GOV'T;

EID: 0027358606     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(93)90234-M     Document Type: Article

References (40)

1. Mitomycin C extravasation injuries
2. Cancer statistics
3. Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma
4. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C
5. Forcing a sequential experiment to be balanced
6. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamouscell carcinoma of the head and neck
7. Bioreductive alkylating agents and radiation therapy in the treatment of squamous cell carcinoma of the head and neck region
8. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group Randomized Trial
9. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
10. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program
11. Randomized study of adjuvant chemotherapy for head and neck cancer
12. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program
13. Adjuvant chemotherapy for high-risk squamous-cell carcinoma of the head and neck
14. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells
15. Role of NADPH; cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C
16. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro
17. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic tumor cells in vivo and in vitro
18. Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group
19. Randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract
20. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup Study 0034
21. The effect of local-regional control on distantmetastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG head and neck database
22. Applicability of animal tumor data to cancer therapy in humans
23. Elapsed treatment days—a critical item for radiotherapy quality control review in head and neck trials: RTOG report
24. The management of primary cancers of the oropharynx: Combined treatment or irradiation alone?
25. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma
26. Adjuvant methotrexate escalted to toxicity for resectable stage III and IV squamous head and neck carcinomas—A prospective, randomized study
27. Mitomycin C and radiation.
28. Use of hypoxia-directed drugs in the therapy of solid tumors
29. Modulation of the antineoplastic efficacy of mitomycin C by dicoumarol in vivo
30. Preclinical studies of porfiromycin as an adjunct to radiotherapy
31. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group
32. Analysis of treatment failure patterns
33. Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer
34. Carcinoma of the tonsillar fossa. An update
35. The scope of the problem of primary tumor control
36. A randomized trial of adjuvant chemo therapy in head and neck cancer
37. Ran domized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma Long-term follow-up of RTOG studya 73-03
38. Elective postoperative radiation therapy in Stages III and IV epidermoid carcinoma of the head and neck
39. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer